🇺🇸 Hydroxycarbamid in United States

60 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 60

Most-reported reactions

1. General Physical Health Deterioration — 11 reports (18.33%)
2. Fatigue — 9 reports (15%)
3. Weight Decreased — 9 reports (15%)
4. Asthenia — 5 reports (8.33%)
5. Decreased Appetite — 5 reports (8.33%)
6. Dyspnoea — 5 reports (8.33%)
7. Anaemia — 4 reports (6.67%)
8. Diarrhoea — 4 reports (6.67%)
9. Dysphagia — 4 reports (6.67%)
10. Leukocytosis — 4 reports (6.67%)

Source database →

Frequently asked questions

Is Hydroxycarbamid approved in United States?

Hydroxycarbamid does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Hydroxycarbamid in United States?

Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts is the originator. The local marketing authorisation holder may differ — check the official source linked above.